Petco Health & Wellness Company, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Nov 23, 2026 (27 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Sep 3, 2026 | BNP Paribas | maintain | Underperform → Underperform | — | 51% |
| Sep 3, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Sep 3, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Sep 1, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Jun 4, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jun 4, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Mar 16, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Mar 16, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Mar 12, 2026 | Jefferies | upgrade | Hold → Buy | — | 52% |
| Feb 3, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $3 | 58% |
| Nov 26, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $4 | 58% |
| Sep 3, 2025 | RBC Capital | reiterate | Outperform → Outperform | $4 | 55% |
| Sep 2, 2025 | Guggenheim | reiterate | Neutral → Neutral | $0 | 52% |
| Aug 29, 2025 | Jefferies | maintain | Hold → Hold | $4.15 | 52% |
| Aug 29, 2025 | UBS | maintain | Neutral → Neutral | $3.7 | 54% |
| Aug 29, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $4 | 54% |
| Aug 29, 2025 | Baird | maintain | Neutral → Neutral | $4 | 55% |
| Jun 6, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $4.5 | 54% |
| Jun 6, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $3.5 | 54% |
| Mar 27, 2025 | Goldman Sachs | maintain | Buy → Buy | $4.48 | 54% |
| Mar 27, 2025 | UBS | maintain | Neutral → Neutral | $3.25 | 54% |
| Mar 27, 2025 | RBC Capital | maintain | Outperform → Outperform | $4 | 55% |
| Mar 27, 2025 | Wedbush | maintain | Outperform → Outperform | $4 | 57% |
| Mar 27, 2025 | Baird | maintain | Neutral → Neutral | $3.5 | 55% |
| Mar 18, 2025 | Citigroup | maintain | Neutral → Neutral | $2.75 | 54% |
| Feb 24, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $3 | 54% |
| Jan 21, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $5 | 54% |
| Dec 20, 2024 | RBC Capital | reiterate | Outperform → Outperform | $6 | 55% |
| Dec 6, 2024 | Wedbush | maintain | Outperform → Outperform | $6 | 57% |
| Dec 6, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $6 | 54% |
| Dec 6, 2024 | RBC Capital | maintain | Outperform → Outperform | $6 | 55% |
| Dec 6, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $5 | 54% |
| Oct 18, 2024 | Wedbush | maintain | Outperform → Outperform | $5.5 | 57% |
| Sep 12, 2024 | Citigroup | maintain | Neutral → Neutral | $4.5 | 54% |
| Sep 12, 2024 | Goldman Sachs | maintain | Buy → Buy | $4 | 54% |
| Sep 11, 2024 | RBC Capital | maintain | Outperform → Outperform | $3.5 | 55% |
| Sep 11, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $3 | 54% |
| Sep 11, 2024 | Wedbush | reiterate | Outperform → Outperform | $5 | 57% |
| Jul 19, 2024 | Citigroup | maintain | Neutral → Neutral | $4 | 54% |
| Jul 18, 2024 | Wedbush | maintain | Outperform → Outperform | $5 | 57% |
| May 29, 2024 | Wedbush | reiterate | Outperform → Outperform | $4 | 57% |
| May 24, 2024 | RBC Capital | maintain | Outperform → Outperform | $3 | 55% |
| May 23, 2024 | Wedbush | maintain | Outperform → Outperform | $4 | 57% |
| May 23, 2024 | UBS | maintain | Neutral → Neutral | $3.25 | 54% |
| May 23, 2024 | Needham | reiterate | Buy → Buy | $5 | 50% |
| May 7, 2024 | Citigroup | maintain | Neutral → Neutral | $1.75 | 54% |
| Apr 2, 2024 | B of A Securities | downgrade | Buy → Underperform | $1.5 | 53% |
| Mar 25, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $2 | 54% |
| Mar 20, 2024 | UBS | maintain | Neutral → Neutral | $2.5 | 54% |
No cross-platform signals in the last 90 days